background
influenza
viru
use
character
efficaci
cyclonebas
twostag
person
bioaerosol
sampler
collect
size
fraction
aerosol
viral
particl
method
collison
singlejet
nebul
use
aerosol
attenu
flumist
vaccin
calmair
settl
chamber
viral
particl
captur
bioaerosol
sampler
util
microcentrifug
tube
collect
airborn
particul
first
tube
collect
particl
greater
lm
diamet
second
tube
collect
particl
lm
backup
filter
f
collect
submicron
particl
follow
aerosol
quantit
pcr
use
detect
quantifi
influenza
strain
result
base
qpcr
result
demonstr
aerosol
viral
particl
effici
collect
separ
accord
aerodynam
size
use
twostag
bioaerosol
sampler
viral
particl
collect
lm
backup
filter
lm
bioaerosol
sampler
furthermor
found
detect
viral
particl
twostag
sampler
directli
proport
collect
time
consequ
viral
particl
count
significantli
greater
minut
comparison
minut
aerosol
collect
point
conclus
due
lack
empir
data
aerosol
transmiss
influenza
often
question
use
flumist
demonstr
newli
develop
bioaerosol
sampler
abl
recov
size
fraction
aerosol
viral
particl
sampler
import
tool
studi
viral
transmiss
clinic
set
may
significantli
contribut
toward
understand
mode
influenza
viru
transmiss
influenza
infect
public
health
concern
account
death
hospit
annual
primari
popul
risk
infect
includ
young
children
elderli
adult
immunocompromis
subject
influenza
outbreak
pandem
healthcar
worker
elev
risk
acquir
influenza
infect
due
prolong
period
exposur
influenza
virus
within
healthcar
set
mechan
influenza
viru
dissemin
transmiss
poorli
understood
experiment
studi
shown
influenza
virus
transmit
via
contact
respiratori
secret
larg
droplet
aerosol
small
particl
droplet
nuclei
mucou
membran
contact
larg
droplet
expel
respiratori
tract
thought
predomin
mode
influenza
infect
transmit
small
particl
aerosol
droplet
nuclei
also
concern
due
potenti
prolong
airborn
suspens
given
epidem
potenti
public
health
concern
newli
emerg
diseas
avian
influenza
sever
acut
respiratori
syndrom
sar
import
develop
method
studi
aerosol
viral
particl
measur
would
enabl
improv
monitor
detect
virus
importantli
would
help
prevent
widespread
transmiss
date
sever
bioaerosol
sampler
avail
use
impact
imping
sampl
methodolog
viral
aerosol
detect
howev
limit
exist
within
method
poor
collect
effici
limit
sampl
time
inabl
separ
particl
base
size
complic
studi
viral
aerosol
mani
environ
would
desir
sampl
viral
aerosol
eg
hospit
airport
level
biolog
relev
particl
bacteria
fungi
pollen
also
high
base
onestag
cyclonebas
bioaerosol
sampler
develop
nation
institut
occup
safeti
health
niosh
twostag
cyclonebas
bioaerosol
sampler
recent
fabric
twostag
bioaerosol
sampler
lightweight
devic
use
either
area
sampler
eg
hospit
room
person
breath
zone
airsampl
devic
worn
lapel
subject
eg
healthcar
worker
bioaerosol
sampler
contain
two
microcentrifug
tube
backup
filter
separ
airborn
particul
base
aerodynam
diamet
first
tube
sampler
collect
particl
greater
approxim
lm
diamet
second
tube
collect
particl
lm
diamet
backup
filter
f
collect
submicron
particul
sampl
deposit
directli
microcentrifug
tube
sampler
facilit
direct
process
sampl
downstream
diagnost
applic
quantit
polymeras
chain
reaction
qpcr
enzymelink
immunosorb
assay
bioaerosol
sampler
potenti
elimin
sever
limit
associ
air
sampl
devic
sampl
loss
contamin
degrad
proof
concept
studi
character
util
twostag
bioaerosol
sampler
fraction
viral
particl
separ
particul
influenza
viru
vaccin
flumist
formula
purchas
medimmun
vaccin
inc
gaithersburg
md
usa
flumist
live
trival
vaccin
compos
new
caledonia
california
b
jiangsu
b
shanghai
strain
strain
genet
alter
attenu
coldadapt
temperaturesensit
phenotyp
limit
viral
replic
nasal
pharynx
ml
dose
formul
contain
approxim
tcid
median
tissu
cultur
infecti
dose
per
viral
strain
viral
aerosol
flumist
collect
use
twostag
bioaerosol
sampler
two
vertic
refer
sampler
place
bottom
calm
air
aerosol
settl
chamber
describ
previous
bioaerosol
sampler
connect
person
air
sampl
pump
model
skc
eighti
four
pa
aerosol
experi
one
dose
ml
flumist
dilut
ml
salin
nacl
one
millilit
solut
initi
drawn
assay
remaind
place
collison
singlejet
nebul
bgi
incorpor
waltham
usa
solut
aerosol
kpa
lb
air
pressur
pass
diffus
drier
model
tsi
incorpor
shoreview
mn
usa
mix
l
minut
dri
filter
air
dri
aerosol
flow
top
calm
air
chamber
avoid
possibl
degrad
viru
ozon
unavoid
byproduct
bipolar
ioniz
employ
earlier
studi
use
instead
conduct
line
settl
chamber
metal
ground
previou
test
calm
air
chamber
indic
precaut
suffici
avoid
electrostat
aerosol
deposit
concentr
size
distribut
dilut
aerosol
record
use
aerodynam
particl
sizer
ap
model
tsi
drew
air
vertic
probe
place
height
bioaerosol
sampler
inlet
start
experi
nebul
oper
minut
allow
aerosol
concentr
reach
equilibrium
minut
sampl
pump
vacuum
sourc
activ
simultan
sampler
aerosol
collect
studi
sampler
pump
switch
minut
refer
sampler
switch
minut
aerosol
collect
exterior
sampler
disinfect
conflikt
decon
lab
king
prussia
pa
usa
collect
tube
filter
remov
analysi
ml
aliquot
solut
remain
nebul
also
remov
analysi
particl
sizesegreg
characterist
twostag
sampler
report
previous
rang
particl
size
use
inform
particl
size
number
data
ap
estim
made
rel
amount
viral
materi
collect
first
second
tube
backup
filter
estim
compar
actual
proport
viral
materi
found
stage
sampler
measur
qpcr
indic
twostag
sampler
separ
aerosol
particl
base
size
expect
viral
rna
extract
use
magmax
tm
viral
rna
isol
kit
ambion
austin
tx
usa
briefli
suppli
lysi
bind
solut
supplement
carrier
rna
use
extract
viral
rna
either
neat
flumist
qpcr
standard
experiment
sampl
backup
filter
f
bioaerosol
sampler
asept
remov
immers
ml
supplement
lysi
bind
solut
vortex
moder
speed
minut
viral
lysi
rna
bind
magnet
captur
wash
dri
rnabound
bead
carri
accord
manufactur
instruct
cdna
gener
revers
transcript
isol
viral
rna
use
taqman
tm
revers
transcript
reagent
appli
biosystem
foster
citi
ca
usa
brief
viral
rna
ad
rtpcr
mixtur
contain
rt
buffer
mm
mgcl
mm
dntp
mix
mm
random
hexam
rnase
inhibitor
u
ml
multiscrib
revers
transcriptas
u
ml
ad
final
final
volum
sampl
briefli
centrifug
place
thermo
hybaid
thermocycl
ashford
uk
run
follow
condit
minut
minut
minut
control
without
templat
run
experi
pilot
studi
simul
biolog
complex
aerosol
one
might
encount
field
situat
flumist
mix
fungal
spore
aerosol
collect
aspergillu
versicolor
atcc
american
type
cultur
collect
grown
malt
extract
agar
day
spore
isol
previous
describ
spore
concentr
determin
hemacytomet
count
coaerosol
one
dose
flumist
dilut
ml
nacl
contain
versicolor
spore
ml
rnasecur
reagent
ambion
inhibit
viral
rna
degrad
aerosol
gener
use
collison
singlejet
nebul
pass
diffus
drier
mix
dri
filter
air
use
experiment
procedur
describ
aerosol
collect
twostag
sampler
two
refer
sampler
two
twostag
sampler
one
refer
sampler
collect
aerosol
minut
remain
sampler
collect
aerosol
minut
genom
dna
extract
versicolorcontain
sampl
describ
griffin
et
al
briefli
buffer
supplement
rnase
dneasi
plant
mini
kit
qiagen
valencia
ca
usa
ad
spore
qpcr
standard
experiment
sampl
filter
elut
ml
supplement
buffer
vortex
minut
transfer
microcentrifug
tube
approxim
mg
mm
zirconia
silica
bead
biospec
product
inc
bartlesvil
ok
usa
ad
sampl
sampl
beadbeaten
maximum
speed
biospec
product
inc
minut
chill
ice
minut
beadbeat
cool
step
repeat
twice
sampl
centrifug
minut
g
protein
precipit
wash
dri
fungal
dna
carri
accord
manufactur
instruct
primer
probe
design
optim
realtim
pcr
primer
probe
specif
target
influenza
surfac
glycoprotein
design
use
primer
express
softwar
appli
biosystem
sequenc
inform
versicolor
obtain
us
environment
protect
agenc
http
wwwepagovmicrobesmoldtechhtm
synthesi
primer
probe
perform
appli
biosystem
tabl
list
sequenc
dye
label
primer
probe
use
qpcr
detect
determin
optim
primer
concentr
qpcr
analysi
optim
qpcr
matrix
perform
primer
probe
combin
singleplex
optim
primer
probe
concentr
use
qpcr
detect
rang
nm
detect
influenza
versicolor
aerosol
sampl
gener
viral
cdna
fungal
genom
dna
respect
ad
appli
biosystem
taqman
tm
univers
pcr
master
mix
appropri
concentr
primer
tamralabel
probe
ad
brought
final
reaction
volum
pcrgrade
water
reaction
run
use
appli
biosystem
realtim
pcr
system
follow
condit
minut
minut
cycl
second
minut
order
quantifi
rel
amount
viral
particl
fungal
spore
collect
stage
bioaerosol
sampler
qpcr
perform
parallel
use
either
serial
dilut
cdna
gener
singl
dose
nonaerosol
flumist
contain
approxim
tcid
per
influenza
strain
genom
dna
isol
spore
neg
control
without
templat
includ
qpcr
reaction
statist
analysi
conduct
experiment
setup
repeatedmeasur
anova
main
effect
stage
time
stage
threelevel
categor
variabl
factor
tube
tube
backup
filter
determin
effect
time
measur
taken
minut
proc
mix
sa
sa
institut
cari
nc
usa
use
analyz
data
signific
calcul
regress
paramet
proc
mix
also
use
insur
similar
experi
test
variabl
replic
result
consid
signific
p
standard
curv
gener
influenza
strain
use
serial
dilut
cdna
isol
singl
dose
flumist
tcid
viral
strain
qpcr
detect
versicolor
standard
curv
gener
use
genom
dna
isol
spore
serial
dilut
standard
curv
versicolor
linear
rang
particl
unabl
gener
reproduc
signal
b
strain
viru
use
specif
primer
design
standard
curv
use
extrapol
rel
viral
spore
number
unknown
sampl
use
titer
report
manufactur
hemacytomet
count
respect
flumist
aerosol
virusladen
aerosol
calm
air
chamber
typic
contain
particl
cm
median
aerodynam
diamet
lm
geometr
standard
deviat
part
method
develop
optim
backup
filter
composit
viru
collect
determin
four
bioaerosol
sampler
fit
differ
type
filter
gelatin
glass
fiber
ptfe
polyvinyl
chlorid
follow
minut
collect
sever
gelatin
filter
found
fractur
rna
extract
glass
fiber
filter
releas
high
number
particul
presum
interf
qpcr
detect
base
initi
experiment
run
ptfe
filter
found
optim
recoveri
viral
particl
figur
subsequ
aerosol
experi
perform
ptfe
filter
character
collect
effici
bioaerosol
sampler
three
ident
experi
perform
figur
b
illustr
collect
result
viral
aerosol
collect
minut
collect
viral
particl
twostag
sampler
linear
minut
viral
particl
count
significantli
greater
minut
comparison
minut
collect
time
p
furthermor
predict
aerodynam
particl
size
data
greatest
proport
viral
particl
detect
backup
filter
f
regardless
collect
time
strain
minut
viral
particl
detect
stage
f
particl
detect
likewis
strain
particl
detect
stage
f
particl
detect
stage
result
consist
throughout
experi
demonstr
abil
bioaerosol
sampler
separ
particl
base
aerodynam
size
similar
distribut
particl
recov
unknown
reason
absolut
particl
number
significantli
lower
examin
effect
bioaerosol
sampler
separ
mix
aerosol
particl
coaerosol
flumist
versicolor
spore
aerodynam
diamet
lm
follow
minut
aerosol
figur
bioaerosol
sampler
abl
separ
particl
differ
size
qpcr
spore
count
confirm
stage
retain
versicolor
spore
stage
spore
found
contain
greatest
amount
viral
particl
overal
shift
deposit
viral
particl
toward
observ
coaerosol
versicolor
spore
significantli
fewer
viral
particl
detect
backup
filter
f
comparison
backup
filter
f
use
flumist
alon
suggest
interact
aggreg
particl
aerosol
need
rapid
accur
method
detect
airborn
virus
increas
recent
year
particularli
follow
report
outbreak
avian
influenza
sar
variou
aerobiolog
monitor
studi
shown
high
degre
variabl
captur
recov
detect
aerosol
viral
particl
environment
clinic
sampl
use
niosh
bioaerosol
sampler
abl
overcom
common
viral
particl
sampl
limit
fraction
aerosol
influenza
particl
artifici
gener
aerosol
bioaerosol
vari
size
concentr
composit
settl
time
aerodynam
particl
sizer
use
monitor
concentr
size
distribut
flumist
aerosol
within
settl
chamber
use
bioaerosol
sampler
could
demonstr
captur
recoveri
subsequ
detect
sampler
stage
f
consist
expect
valu
base
particl
size
anticip
qpcr
result
confirm
signific
number
aerosol
viral
particl
local
within
stage
f
result
agreement
sampler
cutoff
size
lm
stage
f
respect
small
number
aerosol
particl
detect
stage
attribut
collect
effici
bioaerosol
sampler
engin
design
bioaerosol
sampler
critic
sizefraction
bioaerosol
sampl
time
must
also
taken
consider
qpcr
result
aerosol
viral
sampl
collect
minut
confirm
sampl
time
minut
yield
highest
quantiti
viral
particl
howev
necessarili
repres
ideal
environment
sampl
time
quantiti
aerosol
influenza
viru
expel
patient
yet
evalu
aerobiolog
studi
use
differ
viral
strain
found
prolong
sampl
period
result
decreas
viral
recoveri
likewis
influenza
virus
stress
sensit
possibl
exist
lengthier
sampl
time
may
result
desicc
viralladen
aerosol
consequ
compromis
stabil
futur
studi
aim
address
effect
prolong
sampl
time
viral
recoveri
stabil
use
bioaerosol
sampler
collect
aerosol
within
dispos
microcentrifug
tube
limit
sampl
loss
contamin
moreov
sampl
directli
process
within
respect
tube
analyz
differ
diagnost
method
includ
immunoassay
molecular
detect
techniqu
qpcr
current
qpcr
prefer
methodolog
rapid
sensit
detect
virus
howev
sever
limit
still
exist
sensit
specif
qpcr
detect
limit
target
templat
studi
primer
probe
design
select
amplifi
ha
na
gene
strain
respect
interestingli
result
show
consider
differ
number
viral
particl
detect
strain
flumist
vaccin
formul
contain
equival
concentr
viral
strain
use
median
cultur
infecti
dose
tcid
assay
account
nonviabl
viral
particl
qpcr
detect
viral
cdna
viabl
nonviabl
viral
particl
perhap
explain
discrep
qpcr
detect
strain
b
errat
result
obtain
qpcr
detect
success
strain
may
due
presenc
inhibitor
reaction
instead
like
due
poor
primer
probe
design
presenc
secondari
flumist
coaerosol
togeth
calm
air
chamber
sampl
collect
minut
analyz
influenza
virus
use
qpcr
versicolor
use
qpcr
hemacytomet
count
data
stage
present
percentag
total
number
particl
collect
three
stage
spore
count
averag
eight
replic
hemacytomet
count
valu
flumist
fungal
spore
taken
previou
experi
present
tabl
repres
combin
averag
valu
strain
structur
influenza
b
rna
result
poor
revers
transcript
insuffici
target
templat
environment
bioaerosol
vari
consider
may
consist
number
differ
microorgan
includ
virus
bacteria
fungi
recent
find
lindsley
et
al
demonstr
twostag
bioaerosol
sampler
effect
collect
separ
aerosol
fungal
spore
fragment
result
current
studi
provid
support
evid
bioaerosol
sampler
abl
success
recov
sizefraction
viralladen
aerosol
culmin
result
suggest
bioaerosol
sampler
would
ideal
airsampl
devic
aerobiolog
monitor
variou
microorgan
within
occup
environ
howev
preliminari
find
coaerosol
studi
suggest
fraction
environment
sampl
may
complex
name
overal
shift
viral
particl
deposit
presenc
versicolor
spore
observ
shift
viral
particl
deposit
may
attribut
attach
viral
particl
versicolor
spore
ap
data
shown
suggest
particl
adher
one
anoth
given
viral
sporeladen
solut
premix
prior
aerosol
remain
unclear
whether
bind
may
occur
aerosol
within
calmair
settl
chamber
futur
studi
elabor
use
bioaerosol
sampler
captur
effect
sizefraction
coaerosol
particl
differ
speci
current
conflict
view
whether
influenza
virus
spread
direct
contact
secret
larg
droplet
transmiss
aerosol
transmiss
due
lack
virtual
environment
data
aerosol
transmiss
influenza
virus
often
overlook
possibl
mode
transmiss
studi
aerosol
flumist
demonstr
recoveri
aerosol
viral
particl
use
bioaerosol
sampler
detect
influenza
qpcr
whether
aerosol
influenza
particl
signific
contributor
influenza
transmiss
work
environ
commun
remain
determin
futur
experi
focu
studi
dissemin
viralladen
aerosol
util
artifici
cough
gener
simul
cough
dispers
influenza
virus
within
roomsiz
aerosol
chamber
find
would
significantli
contribut
toward
understand
transmiss
aerosol
influenza
viral
particl
furthermor
test
bioaerosol
sampler
healthcar
set
monitor
preval
airborn
influenza
viral
particl
studi
transmiss
influenza
via
inhal
aerosol
viral
particl
studi
help
elucid
rout
transmiss
influenza
would
ultim
contribut
better
patient
manag
well
improv
infect
control
guidelin
decreas
worker
health
risk
